These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling. Tabusa H, Brooks T, Massey AJ. Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484 [Abstract] [Full Text] [Related]
6. Regulation of P21-activated kinase-4 by progesterone and tumor necrosis factor-α in human endometrium and its increased expression in advanced-stage endometriosis. Kim SH, Kim SR, Ihm HJ, Oh YS, Chae HD, Kim CH, Kang BM. J Clin Endocrinol Metab; 2013 Feb; 98(2):E238-48. PubMed ID: 23293332 [Abstract] [Full Text] [Related]
7. Overexpression of p21-activated kinase 1 promotes endometrial cancer progression. Lu W, Qu JJ, Li BL, Lu C, Yan Q, Wu XM, Chen XY, Wan XP. Oncol Rep; 2013 Apr; 29(4):1547-55. PubMed ID: 23338047 [Abstract] [Full Text] [Related]
8. P21-activated kinase 1 and 4 were associated with colorectal cancer metastasis and infiltration. Song B, Wang W, Zheng Y, Yang J, Xu Z. J Surg Res; 2015 Jun 01; 196(1):130-5. PubMed ID: 25791829 [Abstract] [Full Text] [Related]
9. p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion. Lu W, Xia YH, Qu JJ, He YY, Li BL, Lu C, Luo X, Wan XP. Neoplasma; 2013 Jun 01; 60(5):493-503. PubMed ID: 23790167 [Abstract] [Full Text] [Related]
12. BAG-1 expression in normal endometrium, endometrial hyperplasia and endometrial cancer. Song JY, Kim JW, Lee JK, Lee NW, Yeom BW, Kim SH, Lee KW. Acta Obstet Gynecol Scand; 2008 Jun 01; 87(8):862-7. PubMed ID: 18704778 [Abstract] [Full Text] [Related]
15. Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium. Kim KH, Choi JS, Kim JM, Choi YL, Shin YK, Lee HC, Seong IO, Kim BK, Chae SW, Kim SH. Histol Histopathol; 2009 Mar 01; 24(3):309-16. PubMed ID: 19130400 [Abstract] [Full Text] [Related]
16. [Expression and clinical significance of MIIP and PAK1 in endometrial carcinoma]. Jiang S, Tian WY, Yan Y, Teng F, Gao JP, Wang YM, Xue FX. Zhonghua Zhong Liu Za Zhi; 2018 May 23; 40(5):359-364. PubMed ID: 29860763 [Abstract] [Full Text] [Related]
17. Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. Holm C, Rayala S, Jirström K, Stål O, Kumar R, Landberg G. J Natl Cancer Inst; 2006 May 17; 98(10):671-80. PubMed ID: 16705121 [Abstract] [Full Text] [Related]
18. Estrogen receptor-alpha phosphorylation at serine 305, nuclear p21-activated kinase 1 expression, and response to tamoxifen in postmenopausal breast cancer. Bostner J, Skoog L, Fornander T, Nordenskjöld B, Stål O. Clin Cancer Res; 2010 Mar 01; 16(5):1624-33. PubMed ID: 20179234 [Abstract] [Full Text] [Related]
19. Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis. Kim SH, Lee HW, Kim YH, Koo YH, Chae HD, Kim CH, Lee PR, Kang BM. Hum Reprod; 2009 May 01; 24(5):1133-41. PubMed ID: 19168872 [Abstract] [Full Text] [Related]
20. p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease. Siu MK, Yeung MC, Zhang H, Kong DS, Ho JW, Ngan HY, Chan DC, Cheung AN. Am J Pathol; 2010 Jun 01; 176(6):3015-22. PubMed ID: 20413688 [Abstract] [Full Text] [Related] Page: [Next] [New Search]